HROW, US4158581094

Harrow Inc. stock dips after valuation signal highlights potential upside

Published on 09/18/2026 at 17:28 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Harrow Inc. stock closed at USD 33.09 on September 17, 2026, down 3.2 percent and well below a GF Value estimate of USD 43.74. Analyst forecasts for 2026 point to strong revenue and EPS growth for the company.

HROW, US4158581094, Illustration mit AI erstellt.
HROW, US4158581094, Illustration mit AI erstellt.

Harrow Inc. stock (ISIN US4158581094) finished at USD 33.09 on Nasdaq on September 17, 2026, reflecting a 3.2 percent decline and leaving the shares well below a GF Value estimate of USD 43.74 based on recent valuation data. According to GuruFocus on September 17, 2026, the current price stands about 24.3 percent below the platform’s GF Value estimate of USD 43.74, which frames the latest pullback as a potential valuation opportunity rather than a fundamental deterioration.

Valuation discount after recent price drop

The most immediate catalyst for Harrow Inc. stock is the noted gap between market price and GF Value, which widened after the shares fell 3.2 percent to USD 33.09 on September 17, 2026. GuruFocus reports a 52-week trading range for Harrow Inc. between USD 28.54 and USD 54.85, meaning the latest close leaves the stock closer to its 52-week low than to its high. From an investor’s perspective, the roughly USD 21.76 distance between the current price and the 52-week high underlines how far the shares have retreated from their peak over the past year.

In its analysis, GuruFocus assigns Harrow Inc a GF Score of 79 out of 100, which it describes as an above-average profile relative to other stocks on its platform. Combined with the 24.3 percent discount to the GF Value estimate of USD 43.74, this scoring framework suggests that the latest price weakness is not purely mirrored in the company’s composite quality and performance metrics. For investors, the key question is whether the earnings and revenue trajectory in 2026 can justify a closer alignment of the share price with this valuation benchmark over time.

Analyst forecasts point to strong growth

Beyond the valuation lens, analyst consensus numbers highlight expectations of robust top-line and earnings expansion. According to analyst estimates compiled by Yahoo Finance as of September 17, 2026, the average revenue forecast for the current quarter ending in September 2026 stands at USD 99.07 million, compared with year-ago sales of USD 71.64 million for the same period. This implies revenue growth of about 38.3 percent year-over-year for the quarter, underscoring that expectations for Harrow Inc’s near-term operating performance remain ambitious despite the recent share price pullback.

For the full year 2026, Yahoo Finance shows an average revenue estimate of USD 350.74 million, with the prior-year sales figure at USD 272.30 million. That represents expected annual revenue growth of about 28.8 percent in 2026. On the earnings side, the current-year 2026 consensus for EPS is USD 0.45, and growth estimates compiled on the same page indicate that EPS in 2027 could rise by about 529.44 percent compared with the 2026 level. While such a sharp projected EPS increase for 2027 reflects a highly optimistic scenario, it underlines the extent to which analysts see Harrow Inc entering a phase of accelerated earnings scaling over the medium term.

At the quarterly level, analyst EPS estimates on Yahoo Finance indicate an average EPS expectation of USD 0.32 for the current quarter ending in September 2026 and USD 1.05 for the next quarter ending in December 2026. With the year-ago EPS for the current quarter listed at USD 0.33, the near-term forecast implies a modest decline of about 3.0 percent in EPS for this quarter, even as revenue is projected to grow strongly. For investors, this mix of high revenue growth but flat to slightly lower quarterly EPS can signal a phase of investment or cost pressure that precedes the more substantial EPS ramp forecast for 2027.

Risks and what investors should watch

The gap between Harrow Inc’s strong growth forecasts and its recent share price performance illustrates both opportunity and risk. On one hand, the roughly 24.3 percent discount of the current price to the GF Value estimate of USD 43.74, as highlighted by GuruFocus, suggests that the market is not fully pricing in the expected growth path. On the other hand, the modest projected EPS softness for the current quarter compared with the year-ago level, and the ambitious jump required to reach the 529.44 percent EPS growth target for 2027 relative to 2026, imply execution risk: the company must deliver on margin expansion, cost control and scale-up to close the gap between projections and realized earnings.

For investors, monitoring upcoming quarterly releases and any updates from the company’s investor-relations channel will be important to see whether revenue growth in the range of 28.8 percent year-over-year for 2026 and quarterly sales of around USD 99.07 million in September 2026 translate into sustainable EPS gains. Analyst consensus compiled by Yahoo Finance is based on coverage from nine analysts for revenue and multiple analysts for EPS, which indicates a reasonably broad cross-section of professional expectations but does not eliminate the uncertainty inherent in forecasting an accelerating earnings profile.

Harrow Inc. stock price context

In price terms, Harrow Inc. stock closed at USD 33.09 on Nasdaq on September 17, 2026, with the session’s 3.2 percent decline marking a step down within a broader 52-week range between USD 28.54 and USD 54.85 as reported by GuruFocus. At this level, the shares are only USD 4.55 above their 52-week low and USD 21.76 below their 52-week high, which underscores that, despite solid growth expectations, the stock remains far off its peak and trades at a notable discount to both its historical high and the GF Value benchmark relied upon in the valuation analysis.

Harrow Inc. stock snapshot

  • Company: Harrow Inc.
  • ISIN: US4158581094
  • Ticker: HROW
  • Trading venue: Nasdaq
  • Price (as of September 17, 2026): 33.09 USD
  • Market capitalization: [value] USD (as of September 17, 2026)
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Index membership: [index]

More news and analyses on Harrow Inc. stock

Disclaimer...

en | US4158581094 | HROW | boerse | 70126486 | bgmi